COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead More About CSL Behring's Efforts with COVID-19
Video: What Is Primary Immunodeficiency?
Did you know? An estimated 6 million people worldwide live with serious immune system problems.
Growing a Biotech Ecosystem at Penn State
A gift from CSL Behring helped launch an industrial biotechnology center almost three years ago. The university recently gave…
CSL CEO Gives Keynote at Patient Event
The company has maintained its focus on patients amid the challenges of the pandemic, CSL Limited CEO Paul Perreault said.
Solving Medical Mysteries
Germany’s “Dr. House” and other experts say artificial intelligence can help diagnose rare disease patients.
Infographic: All That Plasma Can Do
From immune system problems to bleeding disorders and more – plasma-based therapies treat many health conditions.
At home in Germany, Alpha 1 Athlete Karen Skålvoll misses travel and competitions. These days, you can find her in the garden…
Listen: Adapting to Change
Podcast features bleeding disorder experts in celebration of World Hemophilia Day.